Home-based FES Training in People With Chronic Stroke
NCT: NCT05849532 · RECRUITING
Brief Summary
This project will examine the feasibility, safety and effect of home-based functional electrical stimulation (FES) applied to different lower limb muscles in combination with task-specific training on gait, balance and mobility in adults with chronic stroke. 30 individuals with chronic stroke will first undergo initial screening and baseline walking, mobility, balance and strength assessments in the laboratory. After determining their eligibility for the study, they will undergo 12-weeks of home-based FES and task-specific training. Following the initial screening (week 1) and pre-intervention assessment (week 2), participants will be trained in the lab for 6 sessions (week 3-4) for a FES home program and then given a FES home kit (FES device and an android tablet). Participants will then undergo home-training for 2 weeks (week 5-6) followed by mid-training assessment (week 7). Again, participants will undergo 4-weeks of home training (week 8-11) and final assessment at the end of training (week 12). This project has the following specific aims: Aim 1: To investigate the feasibility, safety and efficacy of 12-weeks of home-based FES and task-specific training in adults with chronic stroke. Aim 2: To examine the effect of 12-weeks of home-based FES and task-specific training on mobility, gait and balance (anticipatory and reactive balance) in adults with chronic stroke.
Frequently Asked Questions
What is Home-based FES Training in People With Chronic Stroke?
Home-based FES Training in People With Chronic Stroke is a clinical trial registered under NCT05849532. Current status: RECRUITING.
What is the status of NCT05849532?
The current status of NCT05849532 (Home-based FES Training in People With Chronic Stroke) is: RECRUITING.
When did Home-based FES Training in People With Chronic Stroke start?
Home-based FES Training in People With Chronic Stroke started on 2022-12-10.
Official Source
View on ClinicalTrials.gov →Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.